Voglibose with Metformin

Voglibose with Metformin is a combination medication used in the management of type 2 diabetes mellitus. It consists of two active ingredients: Voglibose, an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates, and Metformin, a biguanide that improves insulin sensitivity and reduces glucose production in the liver.

Indications

Voglibose with Metformin is indicated for the treatment of type 2 diabetes in adults when diet and exercise alone do not provide adequate glycemic control.

Dosage

The dosage of Voglibose with Metformin should be individualized based on the patient's response and tolerance. Typically, the medication is taken with meals to minimize gastrointestinal side effects. Consultation with a healthcare professional is crucial for determining the appropriate dosage.

Contra-Indications

Voglibose with Metformin is contraindicated in individuals with: -Hypersensitivity to voglibose, metformin, or any other components of the formulation. -Severe renal impairment or renal failure. -Acute or chronic metabolic acidosis, including diabetic ketoacidosis.

Special Precautions

Before initiating Voglibose with Metformin, healthcare providers should exercise caution in patients with: -Impaired liver function. -Heart failure or history of it. -Conditions predisposing to renal dysfunction. -Elderly patients. Regular monitoring of renal function, liver function, and blood glucose levels is recommended during treatment.

Side Effects

Common side effects of Voglibose with Metformin may include gastrointestinal symptoms like flatulence, abdominal discomfort, and diarrhea. Hypoglycemia may occur when combined with other antidiabetic medications.

Drug Interactions

Voglibose with Metformin may interact with: -Diuretics -Corticosteroids -Cimetidine -Beta-2 agonists -Danazol It is essential to inform healthcare providers about all medications being taken to avoid potential interactions.